Abstract
Following stroke, injury, or exposure to physically limiting conditions, limbs can become physiologically compromised. In particular, motor and fine-dexterity tasks involving the arm, particularly in locomotion, grasp and release, can be influenced becoming either delayed and having to deal with greater force demands. Current prosthetic systems use electromyography (EMG)-based techniques for creating functional sensorimotor platforms. However, several limitations in practical use and signal detection have been identified in these systems. Accelerometer-based sensorimotor systems have been suggested to overcome these limitations but only proof-of-concept has been demonstrated. Here, we explore design specifications for accelerometers being developed for prosthetic integration. We have developed optimizations for the current model, evaluated system properties to enhance sensitivity and reduce signal noise, and performed a pilot test using simulation to test this model. The data suggest these novel design parameters can enhance signal detection, when compared to conventional accelerometers. Future avenues should focus on validation of this design prototype in a full prosthetic system.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We would like to acknowledge the project grant support received from Canada Service Corps, TakingITGlobal and the Government of Canada.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
None required. No participants were involved and all modelling was performed using computer applications and software.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail: jcj2{at}ualberta.ca, mardon{at}ualberta.ca
Data Availability
All data supporting the findings of this study are available from the corresponding author [PAJ] on request.